LifeMD (LFMD) Net Equity Issued and Repurchased (2012 - 2025)

LifeMD (LFMD) posted Net Equity Issued and Repurchased of -$21717.0 for Q4 2025, down 100.25% on a QoQ basis from $8.7 million in Q3 2025.

LifeMD (LFMD) Net Equity Issued and Repurchased (2012 - 2025) Analysis & Trends

LifeMD's Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at -$21717.0 for Q4 2025.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$21717.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $167.3 million (changed N/A YoY) and the FY2025 annual result came in at $8.7 million, changed N/A from the prior year.
Net Equity Issued and Repurchased was -$21717.0 for Q4 2025 at LifeMD, down from $8.7 million in the prior quarter.
Across five years, Net Equity Issued and Repurchased topped out at $149.5 million in Q4 2021 and bottomed at -$21717.0 in Q4 2025.
A 3-year average of $41.8 million and a median of $8.9 million in 2023 frame the typical range for Net Equity Issued and Repurchased.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Veeva Systems	31.81 Bn	24.49 Bn	662.02 Mn	-
2	BrightSpring Health Services	14.76 Bn	13.86 Bn	482.22 Mn	-
3	Healthequity	8.36 Bn	8.10 Bn	256.31 Mn	-
4	Hinge Health	5.91 Bn	5.60 Bn	154.23 Mn	-
5	10x Genomics	5.89 Bn	5.35 Bn	106.18 Mn	-
6	MiniMed	4.45 Bn	4.16 Bn	480.00 Mn	-
7	Waystar Holding	4.41 Bn	4.35 Bn	216.84 Mn	-
8	Doximity	3.93 Bn	3.18 Bn	125.97 Mn	-
9	Privia Health	3.10 Bn	2.68 Bn	-	-
10	LifeMD	169.91 Mn	132.79 Mn	2.85 Mn	-21,717.00

Download Data